We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

112 hedge funds and large institutions have $521M invested in Intersect ENT, Inc in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

430% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $3.05M

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

0% more funds holding

Funds holding: 112112 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

25% less capital invested

Capital invested by funds: $690M → $521M (-$169M)

Holders
112
Holders Change
Holders Change %
0%
% of All Funds
2.46%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
20
Increased
44
Reduced
33
Closed
20
Calls
$16.1M
Puts
$3.05M
Net Calls
+$13.1M
Net Calls Change
+$2.12M
Name Holding Trade Value Shares
Change
Change in
Stake
LI
76
Leap Investments
Illinois
$296K -$115K -6,300 -27%
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
$284K
SEI Investments
78
SEI Investments
Pennsylvania
$278K -$220K -12,086 -42%
HSBC Holdings
79
HSBC Holdings
United Kingdom
$264K +$283K +15,546 New
Jacobs Levy Equity Management
80
Jacobs Levy Equity Management
New Jersey
$254K +$272K +14,930 New
MIM
81
MetLife Investment Management
New Jersey
$238K
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$226K -$5.3K -291 -2%
JP Morgan Chase
83
JP Morgan Chase
New York
$211K -$228K -12,520 -50%
VOYA Investment Management
84
VOYA Investment Management
Georgia
$211K
Nisa Investment Advisors
85
Nisa Investment Advisors
Missouri
$208K +$223K +12,230 New
UBS AM
86
UBS AM
Illinois
$206K -$7.86K -432 -3%
Stifel Financial
87
Stifel Financial
Missouri
$193K +$8.21K +451 +4%
WCM
88
Weld Capital Management
New York
$185K +$198K +10,869 New
PNC Financial Services Group
89
PNC Financial Services Group
Pennsylvania
$174K -$28.9K -1,585 -13%
WG
90
Winton Group
United Kingdom
$174K +$186K +10,201 New
Legal & General Group
91
Legal & General Group
United Kingdom
$171K +$76.4K +4,200 +71%
MLICM
92
Metropolitan Life Insurance Company (MetLife)
New York
$167K
CSS
93
Cubist Systematic Strategies
Connecticut
$110K -$210K -11,544 -64%
Citigroup
94
Citigroup
New York
$94K -$172K -9,456 -63%
QT
95
Quantbot Technologies
New York
$84K -$34.3K -1,885 -28%
Victory Capital Management
96
Victory Capital Management
Texas
$84K +$90.1K +4,951 New
BNP Paribas Financial Markets
97
BNP Paribas Financial Markets
France
$81.6K +$22.4K +1,231 +35%
QT
98
Quantamental Technologies
New York
$78K +$473 +26 +0.6%
Bank of Montreal
99
Bank of Montreal
Ontario, Canada
$46K +$2.15K +118 +5%
AIP
100
Ameritas Investment Partners
Nebraska
$39K

XENT Hedge Fund Activity: Q3 2019 in Review

112 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2019, worth a combined $521M — down 25% from $690M a quarter earlier.

Fund positioning in XENT was balanced in Q3 2019: 20 funds opened new positions, 20 closed out, 44 added to existing stakes and 33 trimmed.

The largest buyer was UBS Group, adding an estimated $25.3M. The largest seller was Invesco, cutting an estimated $31.5M.

  • 112 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $521M of Intersect ENT, Inc stock for Q3 2019, down 25% quarter-over-quarter.
  • 20 funds opened new Intersect ENT, Inc positions in Q3 2019 and 20 closed out, a net change of 0 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2019 was UBS Group, an estimated $25.3M added.
  • The largest Intersect ENT, Inc seller in Q3 2019 was Invesco, an estimated $31.5M sold.

Based on aggregated 13F filings for Q3 2019.